COVID-19-Associated Mold Infection in Critically Ill Patients, Chile

Simple item page
dc.contributor.authorRabagliati, Ricardo
dc.contributor.authorRodriguez, Nicolas
dc.contributor.authorNunez, Carolina
dc.contributor.authorHuete, Alvaro
dc.contributor.authorBravo, Sebastian
dc.contributor.authorGarcia, Patricia
dc.date.accessioned2025-01-20T23:51:13Z
dc.date.available2025-01-20T23:51:13Z
dc.date.issued2021
dc.description.abstractPatients with severe coronavirus disease (COVID-19) may have COVID-19-associated invasive mold infection (CAIMI) develop. We report 16 cases of CAIMI among 146 nonimmunocompromised patients with severe COVID-19 at an academic hospital in Santiago, Chile. These rates correspond to a CAIMI incidence of 11%; the mortality rate for these patients was 31.2%.
dc.fuente.origenWOS
dc.identifier.doi10.3201/eid2705.204412
dc.identifier.eissn1080-6059
dc.identifier.issn1080-6040
dc.identifier.urihttps://doi.org/10.3201/eid2705.204412
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/94792
dc.identifier.wosidWOS:000650121700023
dc.issue.numero5
dc.language.isoen
dc.pagina.final1456
dc.pagina.inicio1454
dc.revistaEmerging infectious diseases
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleCOVID-19-Associated Mold Infection in Critically Ill Patients, Chile
dc.typeartículo
dc.volumen27
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas